반응식
C([O:3][C:4]([C:6]1[O:7][C:8]2[C:14]([N:15]3[CH2:20][CH2:19][N:18]([CH2:21][C:22]4[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=4)[CH2:17][CH2:16]3)=[CH:13][CH:12]=[CH:11][C:9]=2[CH:10]=1)=O)C.[NH:28]1[CH2:31][CH2:30][CH2:29]1>>[N:28]1([C:4]([C:6]2[O:7][C:8]3[C:14]([N:15]4[CH2:20][CH2:19][N:18]([CH2:21][C:22]5[CH:23]=[CH:24][CH:25]=[CH:26][CH:27]=5)[CH2:17][CH2:16]4)=[CH:13][CH:12]=[CH:11][C:9]=3[CH:10]=2)=[O:3])[CH2:31][CH2:30][CH2:29]1참가 물질
3
실험 절차
The compound was prepared according to the procedure disclosed in Example 39c starting from ethyl 7-(4-benzylpiperazin-1-yl)benzofuran-2-carboxylate (1.0 g, 2.74 mmol) (Example 39b) and azetidine (0.20 mL, 3.02 mmol). Yield: 0.52 g (51%).
후처리
- customThe compound was prepared
출처 및 근거
- ORD 기록
- ord-bb7a6692190b4e0a8be926f7b682478f
- 출처 데이터셋
- uspto-grants-2013_02
- 특허 번호
- US08367676B2
연결된 노트
불러오는 중…